Rani M R, Gauzzi C, Pellegrini S, Fish E N, Wei T, Ransohoff R M
Department of Neurosciences, The Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
J Biol Chem. 1999 Jan 22;274(4):1891-7. doi: 10.1074/jbc.274.4.1891.
The beta-R1/I-TAC (interferon-inducible T-cell alpha-chemoattractant) gene encodes an alpha-chemokine that is a potent chemoattractant for activated T-cells. We previously reported that beta-R1 was selectively induced by interferon (IFN)-beta compared with IFN-alpha and that the canonical type I IFN transcription factor interferon-stimulated gene factor 3 (ISGF3) was necessary but not sufficient for beta-R1 induction by IFN-beta. These findings suggested that beta-R1 induction by IFN-beta required an accessory component. To begin characterizing this signaling pathway, we examined the function of TYK2 protein in the IFN-beta-mediated induction of beta-R1. This study was motivated by the observation that beta-R1 could not be induced in TYK2-deficient U1 cells by IFN-beta (Rani, M. R. S., Foster, G. R., Leung, S., Leaman, D., Stark, G. R., and Ransohoff, R. M. (1996) J. Biol. Chem. 271, 22878-22884), an unexpected result because IFN-beta evokes substantial expression of IFN-stimulated genes (ISGs) in U1 cells through a TYK2-independent pathway. We now report beta-R1 expression patterns in U1 cells complemented with wild-type or mutant TYK2 proteins. Complementation with wild-type TYK2 rescued IFN-beta-inducible expression of beta-R1. Cells expressing kinase-deficient deletion or point mutants of TYK2 were refractory to induction of beta-R1 by IFN-beta despite robust expression of other ISGs. Transient transfection analysis of a beta-R1 promoter-reporter confirmed that transcriptional activation of beta-R1 by IFN-beta required competent TYK2 kinase. These studies indicate that the catalytic function of TYK2 is required for IFN-beta-mediated induction of beta-R1. Catalytic TYK2 is the first identified component in an accessory signaling pathway that supplements ISGF3/interferon-stimulated response element signaling for gene induction by type I IFNs.
β-R1/I-TAC(干扰素诱导的T细胞α-趋化因子)基因编码一种α-趋化因子,它是活化T细胞的有效趋化剂。我们先前报道,与干扰素-α相比,β-R1由干扰素-β选择性诱导,并且典型的I型干扰素转录因子干扰素刺激基因因子3(ISGF3)对于干扰素-β诱导β-R1是必需的,但并不充分。这些发现表明,干扰素-β诱导β-R1需要一个辅助成分。为了开始表征这条信号通路,我们研究了TYK2蛋白在干扰素-β介导的β-R1诱导中的功能。这项研究的动机是观察到在TYK2缺陷的U1细胞中,干扰素-β不能诱导β-R1(拉尼,M.R.S.,福斯特,G.R.,梁,S.,利曼,D.,斯塔克,G.R.,和兰索霍夫,R.M.(1996年)《生物化学杂志》271,22878 - 22884),这是一个意想不到的结果,因为干扰素-β通过一条不依赖TYK2的途径在U1细胞中引发干扰素刺激基因(ISGs)的大量表达。我们现在报道在补充了野生型或突变型TYK2蛋白的U1细胞中的β-R1表达模式。用野生型TYK2互补可挽救干扰素-β诱导的β-R1表达。尽管其他ISGs大量表达,但表达TYK2激酶缺陷型缺失或点突变体的细胞对干扰素-β诱导β-R1具有抗性。β-R1启动子 - 报告基因的瞬时转染分析证实,干扰素-β对β-R1的转录激活需要有活性的TYK2激酶。这些研究表明,TYK2的催化功能是干扰素-β介导的β-R1诱导所必需的。催化性TYK2是在一条辅助信号通路中首次鉴定出的成分,该信号通路补充ISGF3/干扰素刺激反应元件信号通路以实现I型干扰素的基因诱导。